Analysts Split on Crypto, Pharma, and Water

Analyst target price moves today show a broad range of calls across sectors. Several names stand out.

META saw its consensus target trimmed slightly to $773.59, down from $777.80. Analysts left their buy-heavy ratings intact. The stock remains widely owned on Wall Street, with 54 buy ratings and no sells.

COIN was another target cut. The consensus price fell to $213.68. Coinbase carries a SI % of FF at nearly 11%, signalling short sellers are still active despite the crypto rally. Three of 34 covering analysts rate it a sell.

On the upside, REGN got a target lift to $827.13. Short interest is just 3.6% of free float. Analysts are largely bullish, with 17 buys and no sells.

AOS — the water heater maker — saw its target nudged down to $70.00 from $70.55. Short interest runs at nearly 9% of free float. The stock has equal buy and sell ratings, a split rarely seen in mid-caps.

BMY got a modest target increase to $64.21. Bristol-Myers has 17 hold ratings versus just one sell, suggesting cautious optimism after a period of pipeline concerns.

AMZN and MA both received small target increases. Both retain overwhelming buy consensus with near-zero sell ratings.